文献速递头颈外科咽喉与嗓音

局部晚期颈淋巴结的下咽癌:先行颈清扫后放化疗的疗效分析

Up-front neck dissection followed by chemoradiotherapy for T1-T3 hypopharyngeal cancer with advanced nodal involvement.
PubMed 文献 · Head Neck · 2021-09-22

本研究回顾性比较41例先行颈淋巴结清扫(UFND)后放化疗与14例单纯放化疗的IVA/B期(T1-T3且≥N2a)下咽癌患者;UFND组5年区域控制率显著优于单纯放化疗组(92% vs 57%,p=0.0001),但总生存与疾病特异生存无显著差异,≥70岁或有肺部疾病史者因吸入性肺炎预后更差。

要点

  • UFND后放化疗区域控制率显著优于单纯放化疗(92% vs 57%,p=0.0001)。
  • 两组5年总生存(61% vs 52%)与疾病特异生存(89% vs 74%)无显著差异。
  • ≥70岁或有肺部疾病史者UFND后因吸入性肺炎预后显著更差。

核心结论

  • 对T1-T3且≥N2a的IVA/B期下咽癌,先行颈淋巴结清扫后放化疗可行且区域控制满意,但需预防吸入性肺炎以改善总生存。

研究设计与样本

  • 回顾性分析41例先行颈淋巴结清扫后放化疗与14例单纯放化疗的IVA/B期(T1-T3且≥N2a)下咽癌患者并比较。

主要发现

  • UFND组与单纯放化疗组5年总生存分别为61%和52%(p=0.1019)。
  • UFND组与单纯放化疗组5年疾病特异生存分别为89%和74%(p=0.2333)。
  • UFND组与单纯放化疗组5年区域控制分别为92%和57%(p=0.0001)。
  • UFND组中年龄≥70岁或有肺部疾病史者因吸入性肺炎预后显著更差。

临床怎么用

  • 对T1-T3且≥N2a的IVA/B期下咽癌可考虑先行颈淋巴结清扫后放化疗以改善区域控制。
  • 对≥70岁或有肺部疾病史者应重点预防吸入性肺炎以改善生存。

局限性

  • 回顾性研究,UFND组41例与单纯放化疗组14例样本量不对称。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The advantage of up-front neck dissection (UFND) followed by chemoradiotherapy (CRT) for hypopharyngeal cancer (HPC) with advanced neck involvement remains controversial. We aimed to determine the indications. METHODS: The data of 41 and 14 patients with stage IVA/B (T1-T3 and ≥N2a) HPC who underwent UFND followed by CRT and received CRT, respectively, were retrospectively analyzed and compared. RESULTS: The 5-year overall survival (OS) and disease-specific survival rates for the UFND and CRT groups were 61% and 52% (p = 0.1019), and 89% and 74% (p = 0.2333), respectively. Moreover, patients aged ≥70 years or those with a pulmonary disease history had a significantly poorer prognosis due to aspiration pneumonia in the UFND group. The 5-year regional control (RC) for the UFND and CRT groups were 92% and 57%, respectively (p = 0.0001). CONCLUSIONS: UFND followed by CRT was feasible with satisfactory RC. To further improve OS, aspiration pneumonia prevention is essential.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Sato MP, Otsuki N, Kitano M, et al. Up-front neck dissection followed by chemoradiotherapy for T1-T3 hypopharyngeal cancer with advanced nodal involvement. Head Neck. 2021. PMID: 34549854. doi:10.1002/hed.26881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。